Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New and emerging treatments for myasthenia gravis. | BMJ Med | 2023 | 37560511 | PubTator, text mining | PubMed |
| A multicentre, prospective, double-blind study comparing the accuracy of autoantibody diagnostic assays in myasthenia gravis: the SCREAM study. | Lancet Reg Health West Pac | 2023 | 37554174 | PubTator, text mining | PubMed |
| Gut microbiota in muscular atrophy development, progression, and treatment: New therapeutic targets and opportunities. | Innovation (Camb) | 2023 | 37539440 | PubTator, text mining | PubMed |
| Causal effect of vitamin D on myasthenia gravis: a two-sample Mendelian randomization study. | Front Nutr | 2023 | 37538922 | PubTator, text mining | PubMed |
| Clinical Characteristics of Myasthenia Gravis Patients with COVID-19 in Guangxi, China: A Case-Control Study. | J Inflamm Res | 2023 | 37525635 | PubTator, text mining | PubMed |
| Clinical trials in myasthenia gravis. | J Neurol | 2023 | 37525018 | PubTator, text mining | PubMed |
| Occurrence and severity of myasthenic crisis in an unselected Turkish cohort of patients with myasthenia gravis. | Front Neurol | 2023 | 37521306 | PubTator, text mining | PubMed |
| Pembrolizumab-Induced Myasthenia Gravis: A Case Report and Review of the Literature. | Cureus | 2023 | 37519591 | PubTator, text mining | PubMed |
| Red Blood Cell Metabolism In Vivo and In Vitro. | Metabolites | 2023 | 37512500 | PubTator, text mining | PubMed |
| Detection of Antibodies against the Acetylcholine Receptor in Patients with Myasthenia Gravis: A Comparison of Two Enzyme Immunoassays and a Fixed Cell-Based Assay. | J Clin Med | 2023 | 37510896 | PubTator, text mining | PubMed |
| A Rare Presentation of Narcolepsy With Cataplexy After Vaccines in a Genetically Susceptible Elderly Woman: A Case Report. | Cureus | 2023 | 37503483 | PubTator, text mining | PubMed |
| Current understanding of CTLA-4: from mechanism to autoimmune diseases. | Front Immunol | 2023 | 37497212 | PubTator, text mining | PubMed |
| [Myasthenic syndrome in a patient with end-stage amyotrophic lateral sclerosis]. | Zh Nevrol Psikhiatr Im S S Korsakova | 2023 | 37490673 | PubTator, text mining | PubMed |
People Diagnosed with Myasthenia Gravis have Lower health-related quality of life and Need More Medical and Caregiver Help in Comparison to the General Population: Analysis of Two Observational Studies. | Adv Ther | 2023 | 37490259 | PubTator, text mining | PubMed |
| WNT-β Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective. | Diseases | 2023 | 37489441 | PubTator, text mining | PubMed |
| Melanoma cells induce dedifferentiation and metabolic changes in adipocytes present in the tumor niche. | Cell Mol Biol Lett | 2023 | 37481560 | PubTator, text mining | PubMed |
| Vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic syndrome in the intensive care unit: a case report. | J Med Case Rep | 2023 | 37480098 | PubTator, text mining | PubMed |
| PCDH7 as the key gene related to the co-occurrence of sarcopenia and osteoporosis. | Front Genet | 2023 | 37476411 | PubTator, text mining | PubMed |
| Serum amino acid profiles in patients with myasthenia gravis. | Amino Acids | 2023 | 37474707 | PubTator, text mining | PubMed |
| The role of Beringia in human adaptation to Arctic conditions based on results of genomic studies of modern and ancient populations. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 37465192 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=23